Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01419275 · ClinicalTrials.gov registry record · NA
Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya Disease and Stroke Patients
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 126
- Enrollment target
NCT01419275: Completed NA study, sponsored by Stanford University.
NCT01419275 is a NA study that has completed, run by Stanford University. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01419275, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
Study Summary
Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya disease and stroke patients
Interventions
- DEVICE Magnetic Resonance Imaging
- DRUG Xenon contrast agent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2009-04 |
| Est. Completion | 2013-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01419275
The ClinicalTrials.gov registry entry for NCT01419275 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT01419275 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01419275 about?
NCT01419275 is a clinical study titled "Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya Disease and Stroke Patients". Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya disease and stroke patients
What is the current status of trial NCT01419275?
This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2009-04. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01419275?
The interventions under investigation include: Magnetic Resonance Imaging (DEVICE), Xenon contrast agent (DRUG).
Who is sponsoring clinical trial NCT01419275?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.